Acorda Therapeutics reported $-20876000 in Pre-Tax Profit for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Pre Tax Profit Change
Acadia Pharmaceuticals ACAD:US $ -112.57M 69.67M
Agios Pharmaceuticals AGIO:US $ -94.77M 3.81M
Amgen AMGN:US $ 2727M 56M
Anika Therapeutics ANIK:US $ -3.71M 5.46M
Arrowhead Research ARWR:US $ 44.37M 107.24M
Biogen BIIB:US $ 903.4M 316.6M
Biomarin Pharmaceutical BMRN:US $ 26.19M 92.76M
Cara Therapeutics CARA:US $ -27749000 5.63M
Clovis Oncology CLVS:US $ -60.29M 2.06M
Cytokinetics CYTK:US $ -86.75M 56.18M
Enanta Pharmaceuticals ENTA:US $ -33.59M 3.44M
Halozyme Therapeutics HALO:US $ 81.63M 20.43M
Heron Therapeutics HRTX:US $ -63.89M 9.24M
Insmed INSM:US $ -94236000 18.78M
Mannkind MNKD:US $ -26M 2.06M
Merck MRK:GR € 1306.2M 218.7M
Moderna Inc MRNA:US 4.23B 1.18B
Neurocrine Biosciences NBIX:US $ 21.4M 35.2M
Novartis NOVN:VX SF 3912M 230M
Pfizer PFE:US $ 11328M 4083M
Sanofi SAN:FP € 2965M 804M
Teva Pharmaceutical TEVA:IT -971000000 796M
Ultragenyx Pharmaceutical RARE:US $ -151.76M 29.32M